Pathogenic TDP-43 in amyotrophic lateral sclerosis
Open Access
- 6 April 2025
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 30 (5) , 104351
Abstract
No abstract availableKeywords
This publication has 131 references indexed in Scilit:
- Regulation of TDP-43 phosphorylation in aging and diseaseGeroScience, 2021
- TDP-43 transports ribosomal protein mRNA to regulate axonal local translation in neuronal axonsActa Neuropathologica, 2020
- The Distinct Traits of the UNC13A Polymorphism in Amyotrophic Lateral SclerosisAnnals of Neurology, 2020
- Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43Acta Neuropathologica, 2015
- CDC7 inhibition blocks pathological TDP‐43 phosphorylation and neurodegenerationAnnals of Neurology, 2013
- The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patientsActa Neuropathologica, 2012
- High frequency ofTARDBPgene mutations in Italian patients with amyotrophic lateral sclerosisHuman Mutation, 2009
- Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathiesActa Neuropathologica, 2009
- Two German Kindreds With Familial Amyotrophic Lateral Sclerosis Due to TARDBP MutationsArchives of Neurology, 2008
- TDP‐43 mutation in familial amyotrophic lateral sclerosisAnnals of Neurology, 2008